2d
GlobalData on MSNFDA to review Sanofi and Regeneron’s Dupixent sBLA for bullous pemphigoidAs Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues ...
Obinutuzumab B-cell depleting therapy is more effective than standard care in treating patients with active proliferative lupus nephritis.
As a result, there is no evidence from controlled studies on the efficacy of different initial doses or drug tapering. The only controlled study suggests that initial prednisone doses ≤ 10 mg is ...
A phase 2 study evaluated the use of ruxolitinib plus standard GVHD prophylaxis in patients with myelofibrosis undergoing ...
b During this visit, the patient was prescribed prednisone 10 mg orally daily and his warfarin dosage was decreased to 9 mg weekly. c During this visit, the patient’s warfarin dosage was ...
This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).
This morning's snow continues to taper off, ending in lake effect snow showers early this evening. Bitterly cold temperatures start the work week. Meteorologist Lori Pinson has your forecast.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results